| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,899 | 5,821 | 5,939 | 25,143 | | Cost of Revenue | (5,145) | 1,418 | 3,727 | 26,652 | | | Gross Profit | 12,044 | 4,403 | 2,212 | (1,509) | | | Operating Expenses | | Research Development |
-
| (2,037) | 2,037 |
-
| | Selling General and Administrative | 14,765 | 8,955 | 4,562 | (14,212) | | Non Recurring | 797 | 151 |
-
| 17,675 | | Others | 7,965 | 6,088 | 3,255 | 7,226 | | | | Total Operating Expenses |
-
| 13,157 |
-
|
-
| | | | Operating Income or Loss | (16,496) | (8,754) | (7,642) | (12,198) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,095) | (1,260) | (146) |
-
| | Earnings Before Interest And Taxes | (14,578) | (10,014) | (7,788) | (12,198) | | Interest Expense | 177 | 76 | 259 | 329 | | Income Before Tax | (14,755) | (10,090) | (8,047) | (12,527) | | Income Tax Expense | (8,082) | (639) | 1,645 | 1,453 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,673) | (9,451) | (9,692) | (13,980) | | | Non-recurring Events | | Discontinued Operations | (25,538) | 1,617 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,211) | (7,834) | (9,692) | (13,980) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,211) | ($7,834) | ($9,692) | ($13,980) |
|
0.51% Nasdaq 
Income Statement
